Hawaii Biotech's Grant - III Round

Hawaii Biotech raised a round of funding on October 31, 2018. Investors include National Institute of Allergy and Infectious Diseases.

Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed expertise…

Articles about Hawaii Biotech's Grant - III Round: